Claire Borkert, M.D., has been working with the East Bay AIDS Center (EBAC) since 1992 and was the co-medical director of the center from 1998 to 2005. She is a guest lecturer on HIV for the University of California-San Francisco/University of California-Berkeley joint medical program. She is also the annual HIV lecturer for the UC-Berkeley School of Optometry.

Dr. Borkert was a social worker for 10 years. She switched careers at age 32 when she went to the University of Tennessee-Memphis Medical School. She completed an internal medicine residency at the County of Alameda Medical Center Primary Track Internal Medicine Program.

Dr. Borkert has been a principal investigator on a number of new antiretroviral agents, including tipranavir, TMC-114 and TMC-125. She is a sub-investigator for the Women's Interagency Health Study and the UC-San Francisco Community Consortium. A grant from UC-San Francisco has allowed EBAC to develop a new collaborative research group, the East Bay AIDS Research Institute, in which EBAC and the Alameda County Medical Center collaborate to provide novel, community-based research protocols that reflect the current population of people living with HIV in the United States.

Dr. Borkert's research group has also developed and initiated a collaboration with other area clinics in order to determine why women enroll (or fail to enroll) in clinical trials.